Ionis Pharmaceuticals Inc (MEX:IONS)
MXN 1,150 (0%) Market Cap: 229.56 Bil Enterprise Value: 231.70 Bil PE Ratio: 0 PB Ratio: 26.77 GF Score: 65/100

Ionis Pharmaceuticals Inc at RBC Capital Markets Global Healthcare Conference Transcript

May 19, 2026 / 12:30PM GMT
Release Date Price: MXN1150
Luca Issi
RBC Capital Markets Inc - Analyst

Thanks, everybody. Luca Issi, Senior Biotech Analyst here at RBC Capital Markets. And today is our great privilege to have Ionis Pharmaceuticals as part of our 2026 Global Healthcare Conference. Representative of the company, we have Holly Kordasiewicz, who is the Chief Development Officer.

Holly, thanks so much for joining us. How are you doing today?

Holly Kordasiewicz
Ionis Pharmaceuticals Inc - Executive Vice President and Chief Development Officer

Great. How are you?

Questions & Answers

Luca Issi
RBC Capital Markets Inc - Analyst

Good. Yes. We have a list of questions. But maybe before we go into the specifics, it will be fantastic if you can maybe talk a little bit big picture about what progress has the organization made over the last few months and kind of most importantly, Ionis?

Holly Kordasiewicz
Ionis Pharmaceuticals Inc - Executive Vice President and Chief Development Officer

Yes, absolutely

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot